Search

everythinglearnresearchcommunity

for

Search:↓

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

Plant-based ingredients are effective and safe for modern skincare products.

Injection lipolysis effectively reduces small fat deposits and should be done with care and proper patient selection.

Facial plastic surgery has evolved to focus on less invasive techniques and innovative technologies for cosmetic and reconstructive procedures.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Minoxidil stimulates hair growth by increasing hair thickness and prolonging growth phase.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Minoxidil improves blood flow and vessel flexibility, potentially helping with vascular stiffness.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Type I interferons play a key role in the development of various skin diseases.

Skin organoids are a promising new model for studying human skin development and testing treatments.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Menopause affects hair and skin; more research needed for treatment.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Human hair keratin fibers have a detailed nano-scale structure that changes with different conditions.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.